Table 2 Five-year survival rate of 150 NSCLC patients according to E-cadherin, N-cadherin status, and tumour vascularity

From: Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients

 

E-cadherin

N-cadherin

Tumour vascularity

Variables

Positive

Negative

P -value

Positive

Negative

P -value

Hypervascular

Hypovascular

P -value

Tumour status

         

 T1

79.1

59.8

0.0328

76.8

68.5

0.7681

70

72.4

0.6472

 T2

59.9

45.5

0.4792

45

57.2

0.512

40

62.5

0.0106

 T3

0.0

25

0.7741

0

33.3

0.0389

0

50

0.4547

 T4

40.4

24.1

0.2268

60

22

0.0909

31.8

37.9

0.9706

Nodal status

         

 N0

73.2

58.4

0.1863

71.3

65.7

0.5415

61.0

76.2

0.0613

 N1,N2,N3

31.1

25.2

0.2680

24.2

27.7

0.6718

26.3

26.5

0.2061

Pathological stage

         

 Stage I

78.4

65.6

0.3910

74.9

72.9

0.6786

70.4

77.8

0.3797

 Stage II

50.0

40.0

0.6728

33.3

45.5

0.4972

25.0

66.7

0.1021

 Stage IIIA

21.4

20.0

0.4972

18.8

22.2

0.4935

22.2

16.7

0.2155

 Stage IIIB

40.4

24.1

0.2268

53.6

25.9

0.2244

31.8

37.9

0.9706

Differentiation

         

 Well

80.7

57.1

0.0284

87.5

63.7

0.1619

68.6

75.0

0.4029

 Moderately

62.2

47.1

0.3806

27.6

64.2

0.1245

41.1

67.3

0.0285

 Poorly

34.8

32.8

0.4907

53.3

33.4

0.4948

33.3

44.9

0.1870

Histology

         

 Adenocarcinoma

64.3

46.8

0.0777

68.5

51.1

0.1518

57.3

57.1

0.8660

 Squamous cell carcinoma

68.3

50.4

0.1619

60.0

58.0

0.4981

44.1

68.3

0.0349

 Large cell carcinoma

50.0

30.0

0.4934

0.0

55.6

0.0013

14.3

57.1

0.0535

Total

64.4

45.4

0.0146

59.6

54.0

0.6596

50.8

62.2

0.0378

Back to article page